These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12530942)

  • 21. Pegylated interferon-alfa plus ribavirin therapies for chronic hepatitis C.
    Kanda T; Yokosuka O
    JNMA J Nepal Med Assoc; 2011; 51(181):41-8. PubMed ID: 22335095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peginterferon alfa-2b plus ribavirin for chronic hepatitis.
    Santin M; Shaw E
    Lancet; 2002 Jan; 359(9302):263; author reply 264. PubMed ID: 11812596
    [No Abstract]   [Full Text] [Related]  

  • 23. [Programs for continuing medical education: a session; 2. Current therapy for chronic hepatitis C].
    Imamura M; Chayama K
    Nihon Naika Gakkai Zasshi; 2014 Mar; 103(3):625-9. PubMed ID: 24796128
    [No Abstract]   [Full Text] [Related]  

  • 24. Peginterferon alfa-2b plus ribavirin for chronic hepatitis.
    Picon PD; Costa AF; Kuchenbecker R; Beltrame A
    Lancet; 2002 Jan; 359(9302):263; author reply 264. PubMed ID: 11812597
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of relapsers].
    Galdame O; Manero E; Reggiardo V
    Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S39-41. PubMed ID: 20214298
    [No Abstract]   [Full Text] [Related]  

  • 26. [Differential effects of interferon-based treatments in chronic hepatitis C].
    Nakamoto Y; Kaneko S
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):485-7. PubMed ID: 15359846
    [No Abstract]   [Full Text] [Related]  

  • 27. [Diabetes mellitus during interferon therapy].
    Tarabini-Castellani P; Apraiz L; Portu J; Agud JM
    Enferm Infecc Microbiol Clin; 2008 Feb; 26(2):120-1. PubMed ID: 18341927
    [No Abstract]   [Full Text] [Related]  

  • 28. [Combination therapy of interferon plus ribavirin for chronic hepatitis C].
    Asahina Y; Izumi N
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):467-73. PubMed ID: 15359843
    [No Abstract]   [Full Text] [Related]  

  • 29. [Improved virologic response in chronic hepatitis C treated with peginterferon, ribavirin and add-on drug].
    Hokari A
    Nihon Rinsho; 2011 May; 69 Suppl 4():196-200. PubMed ID: 22096918
    [No Abstract]   [Full Text] [Related]  

  • 30. Tyranny of algorithms in the treatment of patients with hepatitis C.
    Rubin RA
    Hepatology; 2003 Dec; 38(6):1593-4; author reply 1594-5. PubMed ID: 14647072
    [No Abstract]   [Full Text] [Related]  

  • 31. [Exceptional pancytopenia secondary to treatment with pegylated interferon and ribavirin].
    Wikman Jorgensen PE; Jover Díaz FM; Cuadrado Pastor JM
    Gastroenterol Hepatol; 2007 Apr; 30(4):253. PubMed ID: 17408558
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatitis C treatment: interferon free or interferon freer?
    Dusheiko G; Burney T
    Lancet; 2013 Jun; 381(9883):2063-5. PubMed ID: 23499437
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of chronic hepatitis C patients with combination of alpha-interferon and ribavirin, consensus and pegylated interferons.
    Husa P; Husova L
    Bratisl Lek Listy; 2001; 102(5):248-52. PubMed ID: 11725377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Patient, 50, with chronic hepatitis C genotype 1 infection. Therapeutic success despite poor prognosis].
    Klinker H
    MMW Fortschr Med; 2003 Oct; 145(41):39-40. PubMed ID: 14655480
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment strategy for chronic hepatitis C in Japan].
    Arase Y; Kumada H
    Nihon Rinsho; 2011 May; 69 Suppl 4():180-4. PubMed ID: 22096915
    [No Abstract]   [Full Text] [Related]  

  • 36. Amantadine for treatment of hepatitis C: time to say "enough is enough"?
    Piccolo P
    Dig Liver Dis; 2010 Jul; 42(7):468-9. PubMed ID: 20488769
    [No Abstract]   [Full Text] [Related]  

  • 37. Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in patients with hepatitis C virus genotype 1 and slow virological response.
    Pearlman BL; Ehleben C
    Hepatology; 2010 Oct; 52(4):1519-20; author reply 1520-1. PubMed ID: 20879035
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of cirrhotics].
    Galdame O; Jorge A; Sordá J
    Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S42-5. PubMed ID: 20214300
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cutting edge anti-viral therapy for hepatitis C].
    Koike K
    Nihon Shokakibyo Gakkai Zasshi; 2009 Apr; 106(4):479-84. PubMed ID: 19346715
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of elderly patients with chronic hepatitis C].
    Ikeda F; Yamamoto K; Iwasaki Y
    Nihon Rinsho; 2011 May; 69 Suppl 4():221-6. PubMed ID: 22096923
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.